跳至主要内容
临床试验/SLCTR/2021/017
SLCTR/2021/017已完成2 期

Inhaled beclomethasone in the treatment of early COVID-19: a placebo-controlled, randomized trial

Chamila Mettananda0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All consenting males and females above 18 years of age with asymptomatic disease on admission or mild/moderate COVID19 (according to National Institutes of Health criteria) within the first 7 days of symptom onset admitted to District Hospital Kandana with a positive SARS-CoV-2 using a virologic test (i.e., a nucleic acid amplification test [NAAT] or an antigen test).

排除标准

  • 1. Patients refusing consent
  • 2. Age < 18 years
  • 3. Recent use (within 14 days) of inhaled or systemic glucocorticoids
  • 4. Contraindication to beclomethasone
  • 5. Inability to use inhalation device without assistance
  • 6. Patients suffering from psychiatric illnesses lacking the insight to partake fully

研究者

发起方
Chamila Mettananda

相似试验